title: Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives.
abstract: In order to eludicate possible mechanism(s) involved in the blood pressure reduction induced by potassium (K) supplementation, we studied the changes of BP and of some of its regulatory systems, including levels of urinary kallikrein (UKal)--an index of renal kallikrein production. Twenty-four untreated essential hypertensives, with a basal BP of 147/96 +/- 13/7 mmHg and normal renal function, received in crossover, double-blind, randomised fashion, 64 mmol KCl or placebo during two periods of 4 weeks each. At the 4th week of potassium supplementation systolic, diastolic and mean BPs decreased by 6.3 +/- 2 (P less than 0.01), 3.0 +/- 2 and 4.1 +/- 2 (P less than 0.05) mmHg respectively for the supine position, and 5.0 +/- 2, 4.0 +/- 2 (P less than 0.05) and 4.0 +/- 1 (P less than 0.05) mmHg for the standing position. Urinary potassium (K) increased from 55 +/- 4 to 123 +/- 6 mmol/24 hours (P less than 0.001) and UKal from 692 +/- 69 to 1052 +/- 141 mU/24 hours (P less than 0.01). Serum K rose from 3.8 +/- 0.1 mEq/l to 4.1 +/- 0.1 mmol/l (P less than 0.001) and PRA from 0.77 +/- 0.12 to 0.99 +/- 0.14 ng/ml/h (P less than 0.05). Correlations were observed between UKal and urinary K (r = 0.44, P less than 0.0001); between differences in UKal and urinary K and in UKal and urinary Na (r = 0.50, P less than 0.0005 and r = 0.48, P less than 0.001 respectively).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Escuela de Medicina y Facultad de Ciencias Biológicas, Pontificia Universidad Católica, Santiago, Chile.
authors.forename: G
authors.initials: G
authors.lastname: Valdés
authors.forename: C P
authors.initials: CP
authors.lastname: Vio
authors.forename: J
authors.initials: J
authors.lastname: Montero
authors.forename: R
authors.initials: R
authors.lastname: Avendaño
mesh_terms: D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000378:metabolism / Q000502:physiology; D004311:Double-Blind Method; D006801:Humans; D006973:Hypertension / Q000652:urine*; D007610:Kallikreins / Q000652:urine*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000494:pharmacology* / Q000652:urine; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology
chemical_list: D007610:Kallikreins; D011188:Potassium; D001920:Bradykinin